Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.

So go here now to read my new report The Big AI Die-Up… while you still can.

VRNA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.80%

Insider Buying (Last 12 Months): $378,874.24

Insider Selling (Last 12 Months): $183,849.92

Verona Pharma Insider Trading History Chart

Verona Pharma Share Price & Price History

^$28.77

▲ +0.01 (0.03%)

As of 09/30/2024 01:00 AM ET

Days: 30 | 90 | 365

Retire off just one stock ticker?

From Behind the Markets | Ad

ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT make you rich. However, there is one stock that stands head and shoulders above everything else. It's currently trading for only $15...

Click here for the ticker >>>

Verona Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/3/2024	Kathleen A. Rickard	Insider	Sell	36,248	$1.96	$71,046.08	2,621,552
11/20/2023	Martin Edwards	Director	Buy	33,736	$1.84	$62,074.24	144,800
11/6/2023	David R. Ebsworth	Director	Buy	160,000	$1.98	$316,800.00	844,643
11/3/2023	Kathleen A. Rickard	Insider	Sell	58,752	$1.92	$112,803.84	2,840,640
8/7/2023	Claire Poll	General Counsel	Sell	1,512	$2.47	$3,734.64	1,907,367
8/7/2023	David Zaccardelli	CEO	Sell	8,616	$2.47	$21,281.52	16,431,800
8/7/2023	Kathleen A. Rickard	Insider	Sell	1,600	$2.47	$3,952.00	2,872,528
8/4/2023	David Zaccardelli	CEO	Sell	150,000	$2.50	$375,000.00	16,440,416
8/3/2023	Claire Poll	General Counsel	Sell	20,608	$2.54	$52,344.32	1,935,231
8/3/2023	Kathleen A. Rickard	Insider	Sell	50,600	$2.55	$129,030.00	2,902,072
8/3/2023	Mark W. Hahn	CFO	Sell	117,272	$2.54	$297,870.88	15,679,864
8/2/2023	David Zaccardelli	CEO	Sell	73,704	$2.59	$190,893.36	16,707,688
8/1/2023	Claire Poll	General Counsel	Sell	18,608	$2.68	$49,869.44	1,968,783
8/1/2023	Kathleen A. Rickard	Insider	Sell	19,736	$2.68	$52,892.48	2,966,400
8/1/2023	Mark W. Hahn	CFO	Sell	105,944	$2.68	$283,929.92	15,870,840
5/15/2023	Orbimed Advisors Llc	Director	Sell	359,713	$20.08	$7,223,037.04	3,777,778
5/11/2023	Orbimed Advisors Llc	Director	Sell	80,000	$22.26	$1,780,800.00	4,180,691
5/3/2023	Kathleen A. Rickard	Insider	Sell	28,752	$2.65	$76,192.80	2,971,136
5/1/2023	Claire Poll	General Counsel	Sell	80,376	$2.58	$207,370.08	1,979,063
5/1/2023	David Zaccardelli	CEO	Sell	455,536	$2.58	$1,175,282.88	16,887,336
5/1/2023	Kathleen A. Rickard	Insider	Sell	77,424	$2.58	$199,753.92	2,999,888
5/1/2023	Mark W. Hahn	CFO	Sell	455,528	$2.58	$1,175,262.24	15,976,784
2/1/2023	Claire Poll	General Counsel	Sell	152,000	$2.59	$393,680.00	774,256
2/1/2023	David Zaccardelli	CEO	Sell	432,928	$2.56	$1,108,295.68	17,342,872
2/1/2023	Kathleen A. Rickard	Insider	Sell	89,960	$2.56	$230,297.60	3,106,064
2/1/2023	Mark W. Hahn	CFO	Sell	413,168	$2.56	$1,057,710.08	16,432,312
12/22/2022	Claire Poll	General Counsel	Sell	240,000	$2.69	$645,600.00	774,256
12/22/2022	Orbimed Advisors Llc	Director	Sell	3,969,496	$21.77	$86,415,927.92	36,255,896
12/20/2022	David Zaccardelli	CEO	Sell	600,000	$2.12	$1,272,000.00	17,775,800
8/9/2022	David Zaccardelli	CEO	Sell	600,000	$1.75	$1,050,000.00	15,263,560
8/2/2022	Kathleen A. Rickard	Insider	Sell	28,752	$0.70	$20,126.40	2,376,040
8/1/2022	David Zaccardelli	CEO	Sell	32,904	$0.70	$23,032.80	15,863,560
8/1/2022	Mark W. Hahn	CFO	Sell	13,168	$0.70	$9,217.60	14,913,496
5/3/2022	David Zaccardelli	CEO	Sell	32,904	$0.50	$16,452.00	16,351,328
5/3/2022	Kathleen A. Rickard	Insider	Sell	28,752	$0.49	$14,088.48	2,461,224
5/3/2022	Mark W. Hahn	CFO	Sell	12,512	$0.50	$6,256.00	15,381,520
4/11/2022	Kathleen A. Rickard	Insider	Sell	59,720	$0.54	$32,248.80	2,546,408
4/8/2022	Kathleen A. Rickard	Insider	Sell	112,800	$0.59	$66,552.00	2,606,128
2/3/2022	David Zaccardelli	CEO	Sell	52,056	$0.73	$38,000.88
2/2/2022	Mark W. Hahn	CFO	Sell	10,416	$0.76	$7,916.16
2/1/2022	Lisa Deschamps	Director	Sell	11,664	$0.78	$9,097.92
11/2/2021	David Zaccardelli	CEO	Sell	52,056	$0.64	$33,315.84
11/2/2021	Lisa Deschamps	Director	Sell	11,672	$0.66	$7,703.52
11/2/2021	Mark W. Hahn	CFO	Sell	10,416	$0.65	$6,770.40

How a $200,000 Mistake Unlocked a $118 Billion Gold Treasure

From Monument Traders Alliance | Ad

The window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.

Click here now to learn how you can position yourself for potentially massive gains.

SEC Filings (Institutional Ownership Changes) for Verona Pharma (NASDAQ:VRNA)

85.88% of Verona Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Verona Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/27/2024	Clearbridge Investments LLC	405,819	$5.87M	0.0%	+58.8%	0.508%
8/16/2024	Perceptive Advisors LLC	2,433,725	$35.19M	0.8%	-35.3%	3.011%
8/16/2024	Quarry LP	2,000	$29K	0.0%	-63.6%	0.002%
8/16/2024	Frazier Life Sciences Management L.P.	3,314,349	$47.93M	2.2%	+10.0%	4.101%
8/15/2024	The Manufacturers Life Insurance Company	59,418	$0.86M	0.0%	N/A	0.074%
8/15/2024	Millennium Management LLC	527,640	$7.63M	0.0%	+4.7%	0.653%
8/15/2024	Maverick Capital Ltd.	3,092,807	$44.72M	0.8%	+74.2%	3.827%
8/15/2024	Affinity Asset Advisors LLC	700,000	$10.12M	1.2%	-14.4%	0.866%
8/15/2024	Alerce Investment Management L.P.	213,000	$3.08M	6.0%	N/A	0.264%
8/14/2024	NEA Management Company LLC	5,584,753	$80.76M	6.1%	+9.3%	6.910%
8/14/2024	Marshall Wace LLP	13,500	$0.20M	0.0%	N/A	0.017%
8/14/2024	Hood River Capital Management LLC	1,062,456	$15.36M	0.3%	+7.6%	1.315%
8/13/2024	Sei Investments Co.	66,781	$0.97M	0.0%	-10.1%	0.083%
8/12/2024	Resolute Capital Asset Partners LLC	50,000	$0.72M	0.4%	N/A	0.062%
8/9/2024	Renaissance Technologies LLC	31,044	$0.45M	0.0%	N/A	0.038%
8/8/2024	Federated Hermes Inc.	2,163,600	$31.29M	0.1%	-4.2%	2.677%
8/8/2024	American Century Companies Inc.	878,043	$12.70M	0.0%	+56.6%	1.105%
8/8/2024	Rice Hall James & Associates LLC	939,576	$13.59M	0.8%	+39.0%	1.182%
8/7/2024	PFG Investments LLC	44,600	$0.65M	0.0%	+67.7%	0.055%
8/6/2024	Candriam S.C.A.	772,997	$11.18M	0.1%	N/A	0.956%
8/3/2024	TD Asset Management Inc	121,600	$1.76M	0.0%	N/A	0.150%
8/1/2024	Verus Capital Partners LLC	17,385	$0.25M	0.0%	N/A	0.022%
7/30/2024	Matisse Capital	34,400	$0.50M	0.2%	+77.3%	0.043%
7/29/2024	EMC Capital Management	2,500	$38K	0.0%	N/A	0.003%
7/26/2024	Legato Capital Management LLC	10,670	$0.15M	0.0%	N/A	0.013%
7/25/2024	AMI Asset Management Corp	70,000	$1.01M	0.1%	N/A	0.087%
7/20/2024	Hennion & Walsh Asset Management Inc.	135,629	$1.96M	0.1%	+101.3%	0.171%
7/10/2024	CWM LLC	2,000	$29K	0.0%	N/A	0.003%
5/20/2024	Virtu Financial LLC	23,180	$0.37M	0.0%	N/A	0.029%
5/17/2024	Ikarian Capital LLC	375,310	$6.04M	0.7%	+2.1%	0.464%
5/16/2024	Janus Henderson Group PLC	2,031,994	$32.66M	0.0%	+12.7%	2.514%
5/16/2024	Kennedy Capital Management LLC	123,215	$1.98M	0.0%	-25.6%	0.152%
5/15/2024	Bellevue Group AG	1,139,295	$18.33M	0.3%	+35.6%	1.410%
5/15/2024	Hood River Capital Management LLC	987,756	$15.89M	0.4%	+4.3%	1.222%
5/15/2024	Affinity Asset Advisors LLC	817,833	$13.16M	1.7%	+45.1%	1.035%
5/14/2024	CM Management LLC	35,000	$0.56M	0.5%	N/A	0.043%
5/13/2024	Clearbridge Investments LLC	255,609	$4.11M	0.0%	+2.7%	0.316%
5/8/2024	US Bancorp DE	23,822	$0.38M	0.0%	-43.4%	0.029%
5/7/2024	Sei Investments Co.	74,294	$1.20M	0.0%	+3.7%	0.092%
5/2/2024	Jennison Associates LLC	1,593,833	$25.65M	0.0%	+0.5%	1.972%
5/1/2024	Capstone Investment Advisors LLC	25,616	$0.41M	0.0%	N/A	0.032%
5/1/2024	BNP Paribas Financial Markets	23,412	$0.38M	0.0%	+1,054.4%	0.029%
5/1/2024	Matisse Capital	19,400	$0.31M	0.2%	N/A	0.024%
4/29/2024	China Universal Asset Management Co. Ltd.	20,200	$0.33M	0.0%	+35.8%	0.025%
4/23/2024	Rice Hall James & Associates LLC	675,757	$10.87M	0.6%	+44.1%	0.836%
4/22/2024	PFG Investments LLC	26,600	$0.43M	0.0%	+49.4%	0.033%
4/22/2024	Vivo Capital LLC	3,610,177	$58.09M	4.6%	-15.1%	4.467%
4/17/2024	Hennion & Walsh Asset Management Inc.	67,365	$1.08M	0.1%	+71.4%	0.083%
3/5/2024	Wellington Management Group LLP	3,783,994	$75.23M	0.0%	-15.3%	4.734%
2/26/2024	Perceptive Advisors LLC	3,866,214	$76.86M	1.7%	-3.5%	4.836%
2/20/2024	Eventide Asset Management LLC	1,377,781	$27.39M	0.4%	+62.1%	1.724%
2/15/2024	Parkman Healthcare Partners LLC	504,742	$10.03M	1.4%	+20.8%	0.631%
2/14/2024	Avidity Partners Management LP	780,900	$15.52M	0.6%	-5.9%	0.977%
2/14/2024	Superstring Capital Management LP	124,040	$2.47M	1.8%	N/A	0.155%
2/14/2024	Artia Global Partners LP	130,790	$2.60M	0.8%	N/A	0.164%
2/14/2024	Bellevue Group AG	839,996	$16.70M	0.3%	-1.9%	1.051%
2/13/2024	Tower Research Capital LLC TRC	4,495	$89K	0.0%	+950.2%	0.006%
2/13/2024	Affinity Asset Advisors LLC	563,824	$11.21M	2.1%	+53.1%	0.705%
2/13/2024	Campbell & CO Investment Adviser LLC	50,836	$1.01M	0.1%	+1.7%	0.064%
2/12/2024	1492 Capital Management LLC	166,038	$3.30M	1.9%	+1.0%	0.220%
2/12/2024	Cape Investment Advisory Inc.	2,001	$40K	0.0%	N/A	0.003%
2/9/2024	US Bancorp DE	42,102	$0.84M	0.0%	-23.4%	0.053%
2/9/2024	D.A. Davidson & CO.	33,400	$0.66M	0.0%	+2.8%	0.042%
2/9/2024	Clearbridge Investments LLC	248,964	$4.95M	0.0%	N/A	0.311%
2/8/2024	Nicholas Investment Partners LP	169,126	$3.36M	0.4%	-85.5%	0.212%
2/8/2024	First Turn Management LLC	1,206,291	$23.98M	3.4%	N/A	1.509%
2/7/2024	Jump Financial LLC	11,350	$0.23M	0.0%	N/A	0.015%
2/1/2024	New York State Common Retirement Fund	29,669	$0.59M	0.0%	+14.3%	0.037%
2/1/2024	Jennison Associates LLC	1,585,385	$31.52M	0.0%	+9.9%	1.983%
1/26/2024	Moody Aldrich Partners LLC	321,161	$6.39M	1.1%	-9.5%	0.402%
1/24/2024	China Universal Asset Management Co. Ltd.	14,878	$0.30M	0.1%	-73.3%	0.019%
1/17/2024	PFG Investments LLC	17,800	$0.35M	0.1%	N/A	0.022%
1/16/2024	Legato Capital Management LLC	24,329	$0.48M	0.1%	+26.1%	0.030%
12/1/2023	Wellington Management Group LLP	4,467,571	$72.82M	0.0%	+3.8%	5.589%
11/30/2023	American Century Companies Inc.	280,126	$4.57M	0.0%	N/A	0.350%
11/15/2023	Kennedy Capital Management LLC	139,601	$2.28M	0.1%	+19.2%	0.022%
11/15/2023	Adage Capital Partners GP L.L.C.	426,931	$6.96M	0.0%	+95.1%	0.067%
11/15/2023	Affinity Asset Advisors LLC	368,329	$6M	1.7%	-17.7%	0.058%
11/15/2023	Glenmede Trust Co. NA	39,005	$0.64M	0.0%	-12.3%	0.006%
11/14/2023	Eventide Asset Management LLC	850,000	$13.86M	0.2%	N/A	0.134%
11/14/2023	Schonfeld Strategic Advisors LLC	190,406	$3.10M	0.0%	-1.3%	0.030%
11/14/2023	Avidity Partners Management LP	830,300	$13.53M	0.5%	-13.0%	0.131%
11/13/2023	Federated Hermes Inc.	2,493,530	$40.65M	0.1%	+49.3%	0.392%
11/13/2023	Rathbones Group PLC	15,976	$0.26M	0.0%	+66.7%	0.003%
11/13/2023	FMR LLC	6,957,958	$113.42M	0.0%	-2.1%	1.095%
11/8/2023	Campbell & CO Investment Adviser LLC	49,974	$0.82M	0.1%	N/A	0.008%
11/8/2023	Moody Aldrich Partners LLC	354,837	$5.78M	1.1%	+3.8%	0.056%
11/2/2023	Rice Hall James & Associates LLC	25,874	$0.42M	0.0%	N/A	0.004%
11/1/2023	Orion Portfolio Solutions LLC	18,316	$0.30M	0.0%	-4.7%	0.003%
10/31/2023	Jennison Associates LLC	1,442,566	$23.51M	0.0%	+3.9%	0.227%
10/31/2023	Cahill Wealth Management LLC	10,445	$0.17M	0.1%	-13.3%	0.002%
10/31/2023	China Universal Asset Management Co. Ltd.	55,684	$0.91M	0.3%	+166.8%	0.009%
10/24/2023	Bank of New York Mellon Corp	26,478	$0.43M	0.0%	-7.1%	0.004%
8/21/2023	Affinity Asset Advisors LLC	447,667	$9.46M	3.3%	-1.1%	0.070%
8/15/2023	HighVista Strategies LLC	34,027	$0.72M	0.3%	-28.7%	0.005%
8/14/2023	Samsara BioCapital LLC	347,500	$7.35M	1.3%	-50.0%	0.055%
8/14/2023	Caption Management LLC	91,562	$1.94M	0.0%	+357.8%	0.014%
8/14/2023	Bellevue Group AG	572,315	$12.10M	0.2%	+117.9%	0.090%
8/11/2023	HAP Trading LLC	43,805	$0.93M	0.2%	N/A	0.007%
8/10/2023	US Bancorp DE	62,825	$1.33M	0.0%	-10.1%	0.010%

Data available starting January 2016

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. The company was incorporated in 2005 and is headquartered in London, the United Kingdom.

Today's Range

Now: $28.77

$28.36

$29.40

50 Day Range

MA: $26.21

$19.53

$30.16

52 Week Range

Now: $28.77

$11.39

$30.73

Volume

820,526 shs

Average Volume

906,861 shs

Market Capitalization

$2.34 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.44

Who are the company insiders with the largest holdings of Verona Pharma?: Verona Pharma's top insider shareholders include:
Orbimed Advisors Llc (Director)
David Zaccardelli (CEO)
Mark W Hahn (CFO)
Kathleen A Rickard (Insider)
Claire Poll (General Counsel)
David R Ebsworth (Director)
Martin Edwards (Director)
Learn More about top insider investors at Verona Pharma.

My grim warning about AI stocks

From Porter & Company | Ad